ANDA 76706, held by Apotex. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76706 (Metformin Hydrochloride), held by Apotex, was first approved by FDA on Dec 14, 2004, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 14, 2004 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride750MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 1, 2019 | Supplement 14Labeling · Standard review | Approved | None posted |
| Mar 1, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Dec 30, 2009 | Supplement 13Labeling | Approved | None posted |
| Feb 11, 2008 | Supplement 8Labeling | Approved | None posted |
| Nov 7, 2006 | Supplement 6Labeling | Approved | None posted |
| Dec 29, 2005 | Supplement 1Labeling | Approved | None posted |
| Dec 14, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters